Viral vector production for cell and gene therapies
UK businesses can apply for up to £16 million to grow manufacturing capacity for UK viral vector use in advanced therapy medicinal products.
Documents
Details
To lead a project you must:
- be a UK-based business of any size
- manufacture viral vectors either:
- to good manufacturing practice (GMP) standards as gene therapies
- for viral transduction to generate gene-modified cell therapies
Please read the competition scope and guidance for applicants for this competition before you apply.